Related Experiment Video
Updated: May 12, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Integrated proteomic network analysis reveals PTPRC as a central hub protein orchestrating co-expression modules and
Junkai Qin1, Ning Tang2, Dongjun Huang1
1Department of Urology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning 530001, China.
Abstract:
The occurrence of renal carcinoma is closely related to a variety of molecular mechanisms and metabolic disorders. PTPRC (protein tyrosine phosphatase receptor C), as an important regulatory protein, was studied to reveal the role of PTPRC in renal carcinoma through comprehensive proteomic network analysis, especially its core position in the coordination of co-expression modules and metabolic disorders. This study was the first to download and process multiple publicly available renal cancer transcriptome data to conduct differential gene expression analysis across datasets. Functional enrichment and disease ontology analysis were performed on the transcriptome of renal cancer, and weighted gene co-expression network (WGCNA) was constructed. The results showed that comprehensive principal component analysis revealed significant differences in the transcriptome of renal cancer, and functional annotation revealed specific pathways associated with renal cancer. WGCNA analysis identified tumor-associated co-expression modules, while multi-omics analysis further identified core regulatory networks including PTPRC. As a central hub protein, PTPRC plays an important coordinating role in the co-expression module and metabolic dysregulation of renal carcinoma. This discovery provides a new perspective for understanding the molecular mechanism of kidney cancer.
Insights
Protein tyrosine phosphatase receptor C (PTPRC) plays a key role in kidney cancer development by coordinating gene expression and metabolic disorders. This study highlights PTPRC as a central hub in renal carcinoma molecular mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Renal carcinoma is linked to complex molecular and metabolic alterations.
- Understanding these mechanisms is crucial for targeted therapies.
Purpose of the Study:
- To investigate the role of Protein tyrosine phosphatase receptor C (PTPRC) in renal carcinoma.
- To elucidate PTPRC's function in coordinating gene expression modules and metabolic disorders within kidney cancer.
Main Methods:
- Utilized publicly available renal cancer transcriptome data for differential gene expression analysis.
- Performed functional enrichment and disease ontology analysis.
- Constructed a weighted gene co-expression network (WGCNA) and conducted multi-omics analysis.
Main Results:
- Identified significant transcriptomic differences in renal cancer.
- Discovered tumor-associated co-expression modules via WGCNA.
- Uncovered PTPRC as a core regulatory protein and a central hub linking co-expression modules and metabolic dysregulation.
Conclusions:
- PTPRC is a critical coordinating protein in the molecular pathogenesis of renal carcinoma.
- This finding offers novel insights into kidney cancer's molecular mechanisms and potential therapeutic targets.
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein-protein Interfaces

